24 HR glipizide 10 MG Extended Release Oral Tablet — RxCUI 315107
RxNorm drug concept · Semantic clinical drug
RxCUI 315107
Semantic clinical drug · SCD
● Current RxNorm concept 27 FDA products
63 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI315107
Official name24 HR glipizide 10 MG Extended Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asglipizide ER 10 MG 24 HR Extended Release Oral Tablet; glipiZIDE 10 MG 24HR Extended Release Oral Tablet; glipizide XL 10 MG 24 HR Extended Release Oral Tablet
FDA products mapped27
Package NDCs mapped63
Reported Medicaid activity (SDUD)492,505 prescriptions · 50 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Glipizide: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Glipizide helps lower your blood sugar by prompting your pancreas to release more insulin — especially after meals. It's used in type 2 diabetes alongside diet and exercise, not as...
- What exactly is glipizide supposed to do for my diabetes?
- The regular tablet works relatively quickly and is usually taken about 30 minutes before a meal. The extended-release tablet (including the brand Glucotrol XL) releases the medicin...
- What's the difference between the regular tablet and the extended-release tablet?
🕸️ Concept Web — How 24 HR glipizide 10 MG Extended Release Oral Tabl... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
24 HR glipizide 10 MG Extended Release Oral Tablet
RxCUI 315107 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Glipizide
4821IN
-
Glipizide
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Glucotrol
203680BN
-
Glucotrol
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Glipizide Extended Release Oral Tablet
700835SCDF -
Glipizide Oral Product
1165207SCDG -
Glipizide Pill
1165208SCDG -
Glipizide Extended Release Oral Tablet [Glucotrol]
865567SBDF -
Glucotrol Oral Product
1171246SBDG -
Glucotrol Pill
1171247SBDG -
Extended Release Oral Tablet
316945DF -
Oral Product
1151131DFG - +1 more in this family
-
Glipizide Extended Release Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Glipizide 10 MG
317379SCDC -
24 HR glipizide 10 MG Extended Release Oral Tablet [Glucotrol]
865568SBD -
Glipizide 10 MG [Glucotrol]
566720SBDC
-
Glipizide 10 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Glipizide 10 MG
SCDC · 317379 -
Glipizide Extended Release Oral Tablet
SCDF · 700835 -
Glipizide Oral Product
SCDG · 1165207 -
Glipizide Pill
SCDG · 1165208
Brand-Name Concepts
-
24 HR glipizide 10 MG Extended Release Oral Tablet [Glucotrol]
SBD · 865568 -
Glipizide 10 MG [Glucotrol]
SBDC · 566720 -
Glipizide Extended Release Oral Tablet [Glucotrol]
SBDF · 865567 -
Glucotrol Oral Product
SBDG · 1171246 -
Glucotrol Pill
SBDG · 1171247 -
Glucotrol
BN · 203680
📦 FDA Products & Package NDCs
27 products · 63 package NDCs
63 package NDCs map to RxCUI 315107 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00049-0174-02 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0049-0174-02) | Glucotrol XL | Roerig | 2013-05-09 |
| 00049-0174-03 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (0049-0174-03) | Glucotrol XL | Roerig | 2013-05-09 |
| 00049-0178-08 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (0049-0178-08) | Glucotrol XL | Roerig | 2013-05-09 |
| 16714-0894-01 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (16714-894-01) | Glipizide | Northstar Rx LLC. | 2018-12-01 |
| 16714-0895-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (16714-895-01) | Glipizide | Northstar Rx LLC. | 2018-12-01 |
| 16714-0895-02 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (16714-895-02) | Glipizide | Northstar Rx LLC. | 2018-12-01 |
| 16714-0896-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (16714-896-01) | Glipizide | Northstar Rx LLC. | 2018-12-01 |
| 16714-0896-02 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (16714-896-02) | Glipizide | Northstar Rx LLC. | 2018-12-01 |
| 50090-5806-00 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-... | Glipizide | A-S Medication Solutions | 2021-10-15 |
| 50090-5806-01 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-... | Glipizide | A-S Medication Solutions | 2021-10-15 |
| 50090-5806-02 | 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50090-... | Glipizide | A-S Medication Solutions | 2021-10-15 |
| 50090-6765-00 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-6765-0) | Glipizide | A-S Medication Solutions | 2023-10-19 |
| 50090-6765-01 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-6765-1) | Glipizide | A-S Medication Solutions | 2023-10-19 |
| 50090-6765-02 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-6765-2) | Glipizide | A-S Medication Solutions | 2023-10-19 |
| 50090-6848-00 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-6848-0) | Glipizide | A-S Medication Solutions | 2023-11-29 |
| 50090-6848-01 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-6848-1) | Glipizide | A-S Medication Solutions | 2023-11-29 |
| 50090-6848-02 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-6848-2) | Glipizide | A-S Medication Solutions | 2023-11-29 |
| 50090-6849-00 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (50090-6849-0) | Glipizide | A-S Medication Solutions | 2023-11-29 |
| 51655-0966-26 | 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTI... | Glipizide | Northwind Health Company, LLC | 2023-07-31 |
| 51655-0966-52 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTI... | Glipizide | Northwind Health Company, LLC | 2023-06-27 |
| 59651-0780-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (59651-780-30) | Glipizide | Aurobindo Pharma Limited | 2023-03-03 |
| 59651-0781-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (59651-781-01) | Glipizide | Aurobindo Pharma Limited | 2023-03-03 |
| 59651-0781-05 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (59651-781-05) | Glipizide | Aurobindo Pharma Limited | 2023-03-03 |
| 59651-0781-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (59651-781-30) | Glipizide | Aurobindo Pharma Limited | 2023-03-03 |
| 59651-0782-01 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (59651-782-01) | Glipizide | Aurobindo Pharma Limited | 2023-03-03 |
| 59651-0782-05 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (59651-782-05) | Glipizide | Aurobindo Pharma Limited | 2023-03-03 |
| 59651-0782-30 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (59651-782-30) | Glipizide | Aurobindo Pharma Limited | 2023-03-03 |
| 59651-0782-99 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (59651-782-99) | Glipizide | Aurobindo Pharma Limited | 2023-03-03 |
| 60760-0793-90 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (60760-793-... | Glipizide | St. Mary's Medical Park Pharmacy | 2023-12-07 |
| 64980-0279-03 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTI... | Glipizide | Rising Pharma Holdings, Inc. | 2017-04-24 |
| 64980-0280-01 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLAST... | Glipizide | Rising Pharma Holdings, Inc. | 2017-04-24 |
| 64980-0280-05 | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLAST... | Glipizide | Rising Pharma Holdings, Inc. | 2017-04-24 |
| 64980-0280-10 | 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLAS... | Glipizide | Rising Pharma Holdings, Inc. | 2017-04-24 |
| 64980-0281-01 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLAST... | Glipizide | Rising Pharma Holdings, Inc. | 2017-04-24 |
| 64980-0281-05 | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLAST... | Glipizide | Rising Pharma Holdings, Inc. | 2017-04-24 |
| 64980-0281-10 | 1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLAS... | Glipizide | Rising Pharma Holdings, Inc. | 2017-04-24 |
| 68788-7856-01 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLAST... | Glipizide | Preferred Pharmaceuticals Inc. | 2021-01-29 |
| 68788-7856-03 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTI... | Glipizide | Preferred Pharmaceuticals Inc. | 2021-01-29 |
| 68788-7856-06 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTI... | Glipizide | Preferred Pharmaceuticals Inc. | 2021-01-29 |
| 68788-7856-09 | 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTI... | Glipizide | Preferred Pharmaceuticals Inc. | 2021-01-29 |
| 70518-1848-00 | 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTI... | Glipizide | REMEDYREPACK INC. | 2019-02-04 |
| 70518-3896-00 | 30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70518-3896-0) | Glipizide | REMEDYREPACK INC. | 2023-10-17 |
| 70518-4128-01 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-4128... | Glipizide | REMEDYREPACK INC. | 2025-09-08 |
| 71335-1031-01 | 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-... | Glipizide | Bryant Ranch Prepack | 2019-01-07 |
| 71335-1031-02 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-... | Glipizide | Bryant Ranch Prepack | 2019-01-07 |
| 71335-1031-03 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-... | Glipizide | Bryant Ranch Prepack | 2019-01-07 |
| 71335-1031-04 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335... | Glipizide | Bryant Ranch Prepack | 2019-01-07 |
| 71335-1042-01 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-... | Glipizide | Bryant Ranch Prepack | 2019-01-08 |
| 71335-1042-02 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-... | Glipizide | Bryant Ranch Prepack | 2019-01-08 |
| 71335-1130-01 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71335-... | Glipizide | Bryant Ranch Prepack | 2019-03-06 |
Observed labelers:
Bryant Ranch Prepack (18) ·
A-S Medication Solutions (10) ·
Aurobindo Pharma Limited (8) ·
Rising Pharma Holdings, Inc. (7) ·
Northstar Rx LLC. (5) ·
Northwind Health Company, LLC (4)
· +4 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.